The Clinical Research Core is a fundamental and essential core of our NIH-NIDA funded Center. The goals of the core are: 1) To provide highly trained staff (physicians, nurse practitioners, nurses, and assistants for research) at all levels to perform the rigorous inpatient molecular neurobiology studies as detailed in Project 4, as well as an outpatient site for performance of related genetic studies, as well as for subject screening, evaluation, and follow-up. 2) The second goal is to develop or maintain strong on-site relationships with a limited number of large, successful programs delivering primarily pharmacotherapy for heroin addiction using methadone maintenance or buprenorphine maintenance for: a. Recruitment of subjects for studies at The Rockefeller University Hospital b. In some cases, conducting onsite human molecular genetics ascertainment studies with local clinic IRBs' Informed Consent, as well as Rockefeller University IRB Informed Consent, both signed c. To identify new problems, including psychiatric and medical problems, new drug abuse problems confronting these groups, as well as any unexpected positive or adverse responses to specific treatments. A broad spectrum of subjects in the greater New York area are used for recruitment. Our related clinic in Las Vegas, NV, is used primarily for identification of problems and confirming or refuting the generalizability of observations made in the greater New York area in another part of our nation. 3) The third goal is to provide a nurturing and rigorous environment for the training of clinical investigators, including physicians, nurse practitioners, research nurses, counselors, psychologists, and a wide variety of healthcare personnel, including social workers and counselors interested in becoming directly involved in addictive diseases research or for the purpose of general education and training in research medicine and/or addictive diseases treatment.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Comprehensive Center (P60)
Project #
5P60DA005130-24
Application #
8075621
Study Section
Special Emphasis Panel (ZDA1)
Project Start
Project End
Budget Start
2010-06-01
Budget End
2011-05-31
Support Year
24
Fiscal Year
2010
Total Cost
$416,577
Indirect Cost
Name
Rockefeller University
Department
Type
DUNS #
071037113
City
New York
State
NY
Country
United States
Zip Code
10065
Gasser, Paul J; Hurley, Matthew M; Chan, June et al. (2017) Organic cation transporter 3 (OCT3) is localized to intracellular and surface membranes in select glial and neuronal cells within the basolateral amygdaloid complex of both rats and mice. Brain Struct Funct 222:1913-1928
Butelman, Eduardo Roque; Bacciardi, Silvia; Maremmani, Angelo Giovanni Icro et al. (2017) Can a rapid measure of self-exposure to drugs of abuse provide dimensional information on depression comorbidity? Am J Addict 26:632-639
Valenza, Marta; Picetti, Roberto; Yuferov, Vadim et al. (2016) Strain and cocaine-induced differential opioid gene expression may predispose Lewis but not Fischer rats to escalate cocaine self-administration. Neuropharmacology 105:639-650
Garzón, Miguel; Pickel, Virginia M (2016) Electron microscopic localization of M2-muscarinic receptors in cholinergic and noncholinergic neurons of the laterodorsal tegmental and pedunculopontine nuclei of the rat mesopontine tegmentum. J Comp Neurol 524:3084-103
Zhou, Yan; Leri, Francesco; Cummins, Erin et al. (2015) Individual differences in gene expression of vasopressin, D2 receptor, POMC and orexin: vulnerability to relapse to heroin-seeking in rats. Physiol Behav 139:127-35
Zhou, Y; Kreek, M J (2015) Persistent increases in rat hypothalamic POMC gene expression following chronic withdrawal from chronic ""binge"" pattern escalating-dose, but not steady-dose, cocaine. Neuroscience 289:63-70
Zhou, Yan; Kreek, Mary Jeanne (2014) Alcohol: a stimulant activating brain stress responsive systems with persistent neuroadaptation. Neuropharmacology 87:51-8
Mayer-Blackwell, B; Schlussman, S D; Butelman, E R et al. (2014) Self administration of oxycodone by adolescent and adult mice affects striatal neurotransmitter receptor gene expression. Neuroscience 258:280-91
Garzón, Miguel; Pickel, Virginia M (2013) Somatodendritic targeting of M5 muscarinic receptor in the rat ventral tegmental area: implications for mesolimbic dopamine transmission. J Comp Neurol 521:2927-46
Levran, Orna; Peles, Einat; Randesi, Matthew et al. (2013) Association of genetic variation in pharmacodynamic factors with methadone dose required for effective treatment of opioid addiction. Pharmacogenomics 14:755-68

Showing the most recent 10 out of 168 publications